Charles Elliott Sigal - May 23, 2022 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role
Director
Signature
/s/ Howard Horn, Attorney-in-Fact
Stock symbol
VIR
Transactions as of
May 23, 2022
Transactions value $
$0
Form type
4
Date filed
5/25/2022, 06:09 PM
Previous filing
Jul 2, 2021
Next filing
Jun 10, 2022
SEC
View on sec.gov

Transactions Table

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIR Stock Option (Right to Buy) Award $0 +12.8K $0.00 12.8K May 23, 2022 Common Stock 12.8K $24.14 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.